Unusual 11 Mid-Day Movers 04/27: (AWRE) (NPD) (ARNA) Higher; (MXWL) (MDRX) (DECK) Lower
Tweet Send to a Friend
Get Alerts AWRE Hot Sheet
Trade AWRE Now!
Aware (Nasdaq: AWRE) 61.8% HIGHER; has signed an agreement for the sale of selected patents and patent applications to Intel Corporation (Nasdaq: INTC) for approximately $75 million, subject to customary closing conditions and any required regulatory approvals. The company also declared a special dividend of $1.15 per share. Lastly, Aware reported Q1 EPS of $0.05, versus $0.03 reported last year. Revenue for the quarter came in at $5.7 million, versus $6.4 million reported last year.
Maxwell Technologies (Nasdaq: MXWL) 37.7% LOWER; reported Q1 EPS of $0.02, in-line with the analyst estimate of $0.02. Revenue for the quarter came in at $39.2 million versus the consensus estimate of $40.37 million.
Allscripts Healthcare Solutions (Nasdaq: MDRX) 35.6% LOWER; reported Q1 EPS of $0.12, 12 cents worse than the analyst estimate of $0.24. Revenue for the quarter came in at $364.7 million versus the consensus estimate of $387.82 million. Allscripts sees FY2012 EPS of $0.74 to $0.80, versus prior guidance of $1.06 to $1.10 and the consensus of $1.09. Allscripts also announced that Bill Davis, Chief Financial Officer, has decided to leave the Company, effective May 18, 2012, to pursue another opportunity with a private company outside of the healthcare industry. The Company also announced that Phil Pead's service as Chairman of the Board, director and officer of the Company terminated yesterday.
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) 31.1% HIGHER; declared a special dividend of $0.60 per share. The dividend will be payable on June 7, 2012, to stockholders of record on May 7, 2012, with an ex-dividend date of April 27, 2012. The annual yield on the dividend is 24.2 percent.
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) 26.7% HIGHER; surging higher following VIVUS (Nasdaq: VVUS) news that avanafil received FDA approval.
Expedia (Nasdaq: EXPE) 26.5% HIGHER; reported Q1 EPS of $0.26, $0.11 better than the analyst estimate of $0.15. Revenue for the quarter came in at $816.5 million versus the consensus estimate of $791.46 million.
Deckers Outdoor Corp (Nasdaq: DECK) 25.4% LOWER; reported Q1 EPS of $0.20, 5 cents worse than the analyst estimate of $0.25. Revenue for the quarter came in at $246.3 million versus the consensus estimate of $246.48 million. Deckers Outdoor sees Q2 2012 EPS of ($0.60), versus the consensus of ($0.39). Sees Q2 revs up 8 percent.
Telecommunication Systems, Inc. (Nasdaq: TSYS) 21.9% LOWER; reported Q1 EPS of $0.06, $0.01 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $100 million versus the consensus estimate of $104.16 million.
Cray, Inc. (Nasdaq: CRAY) 22.4% HIGHER; reported Q1 EPS of $0.13, $0.10 better than the analyst estimate of $0.03. Revenue for the quarter came in at $112.3 million versus the consensus estimate of $99 million.
TESSCO (Nasdaq: TESS) 21.2% LOWER; sees FY12 EPS of about $2.03, inline with the Street, on sales of $733 million, which compares to the analyst estimate of $721.8 million. Sees FY13 EPS of $1.80-$2.15, vs. the consensus estimate of $2.24.
Abaxis, Inc. (NASDAQ: ABAX) 16.5% HIGHER; reported Q4 EPS of $0.21, $0.04 better than the analyst estimate of $0.17. Revenue for the quarter came in at $42.72 million versus the consensus estimate of $40.68 million.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Maxwell Technologies (Nasdaq: MXWL) 37.7% LOWER; reported Q1 EPS of $0.02, in-line with the analyst estimate of $0.02. Revenue for the quarter came in at $39.2 million versus the consensus estimate of $40.37 million.
Allscripts Healthcare Solutions (Nasdaq: MDRX) 35.6% LOWER; reported Q1 EPS of $0.12, 12 cents worse than the analyst estimate of $0.24. Revenue for the quarter came in at $364.7 million versus the consensus estimate of $387.82 million. Allscripts sees FY2012 EPS of $0.74 to $0.80, versus prior guidance of $1.06 to $1.10 and the consensus of $1.09. Allscripts also announced that Bill Davis, Chief Financial Officer, has decided to leave the Company, effective May 18, 2012, to pursue another opportunity with a private company outside of the healthcare industry. The Company also announced that Phil Pead's service as Chairman of the Board, director and officer of the Company terminated yesterday.
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) 31.1% HIGHER; declared a special dividend of $0.60 per share. The dividend will be payable on June 7, 2012, to stockholders of record on May 7, 2012, with an ex-dividend date of April 27, 2012. The annual yield on the dividend is 24.2 percent.
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) 26.7% HIGHER; surging higher following VIVUS (Nasdaq: VVUS) news that avanafil received FDA approval.
Expedia (Nasdaq: EXPE) 26.5% HIGHER; reported Q1 EPS of $0.26, $0.11 better than the analyst estimate of $0.15. Revenue for the quarter came in at $816.5 million versus the consensus estimate of $791.46 million.
Deckers Outdoor Corp (Nasdaq: DECK) 25.4% LOWER; reported Q1 EPS of $0.20, 5 cents worse than the analyst estimate of $0.25. Revenue for the quarter came in at $246.3 million versus the consensus estimate of $246.48 million. Deckers Outdoor sees Q2 2012 EPS of ($0.60), versus the consensus of ($0.39). Sees Q2 revs up 8 percent.
Telecommunication Systems, Inc. (Nasdaq: TSYS) 21.9% LOWER; reported Q1 EPS of $0.06, $0.01 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $100 million versus the consensus estimate of $104.16 million.
Cray, Inc. (Nasdaq: CRAY) 22.4% HIGHER; reported Q1 EPS of $0.13, $0.10 better than the analyst estimate of $0.03. Revenue for the quarter came in at $112.3 million versus the consensus estimate of $99 million.
TESSCO (Nasdaq: TESS) 21.2% LOWER; sees FY12 EPS of about $2.03, inline with the Street, on sales of $733 million, which compares to the analyst estimate of $721.8 million. Sees FY13 EPS of $1.80-$2.15, vs. the consensus estimate of $2.24.
Abaxis, Inc. (NASDAQ: ABAX) 16.5% HIGHER; reported Q4 EPS of $0.21, $0.04 better than the analyst estimate of $0.17. Revenue for the quarter came in at $42.72 million versus the consensus estimate of $40.68 million.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Streetinsider.com's Hot Lunchtime Reads 05/23: (YHOO) (DELL) (ACI) (AKAM)
- Notable Analyst Rating Changes 05/22: (BMY) (CREE) (TEX) Upgraded; (IGTE) (CCL) (NCT) Downgraded
- Unusual 11 Mid-Day Movers 05/22: (CLNT) (MBND) (ZLC) Higher; (STP) (LDK) (FXEN) Lower
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Dividend, Unusual 11 Mid-Day Movers
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
